HuGE Literature Finder
Records
1
-
30
| Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma. Gynecologic oncology 2022 Feb . Liao Xin, Xia Xuyang, Su Wei, Yan Huayun, Ma Yingfang, Xu Lian, Luo Han, Liu Wanting, Yin Dandan, Zhang Wei-Han, Chen Hai-Ning, Deng Yiqi, Ren Zhixiang, Yu Zehui, Liao Fei, Chen Keling, Cao Minyuan, Zhang Yiguan, Zhang Wei, Wang Wei, Zhao Jun-Ning, Xu Heng, Shu Ya |
| The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification. BMC cancer 2022 Feb 22 (1): 186. Yang Yefan, Ding Ying, Gong Yuxi, Zhao Sha, Li Mingna, Li Xiao, Song Guoxin, Zhai Boya, Liu Jin, Shao Yang, Zhu Liuqing, Pang Jiaohui, Ma Yutong, Ou Qiuxiang, Wu Xue, Zhang Zhiho |
| Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort. International journal of cancer 2020 Nov . Aparicio Thomas, Svrcek Magali, Henriques Julie, Afchain Pauline, Lièvre Astrid, Tougeron David, Gagniere Johan, Terrebonne Eric, Piessen Guillaume, Legoux Jean-Louis, Lecaille Cédric, Pocard Marc, Gornet Jean-Marc, Zaanan Aziz, Lavau-Denes Sandrine, Lecomte Thierry, Deutsch David, Vernerey Dewi, Laurent Puig Pier |
| FoundationOne® CDx gene profiling in Japanese pancreatic ductal adenocarcinoma patients: a single-institution experience. Surgery today 2020 Sep . Kimura Ryuichiro, Ohtsuka Takao, Kubo Makoto, Kajihara Atsuko, Fujii Atsushi, Watanabe Yusuke, Mori Yasuhisa, Ikenaga Naoki, Nakata Kohei, Shindo Koji, Ohuchida Kenoki, Nakamura Masafu |
| Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer. Cancer science 2020 Apr . Yokose Takahiro, Kitago Minoru, Matsuda Sachiko, Sasaki Yasushi, Masugi Yohei, Nakamura Yuki, Shinoda Masahiro, Yagi Hiroshi, Abe Yuta, Oshima Go, Hori Shutaro, Fujita Yusuke, Nakano Yutaka, Endo Yutaka, Abe Kodai, Tokino Takashi, Kitagawa Yu |
| TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Mar . Sinn Marianne, Sinn Bruno V, Treue Denise, Keilholz Ulrich, Damm Frederik, Schmuck Rosa Bianca, Lohneis Philipp, Klauschen Frederick, Striefler Jana K, Bahra Marcus, Bläker Hendrik, Bischoff Sven, Pelzer Uwe, Oettle Helmut, Riess Hanno, Budczies Jan, Denkert Carst |
| Imaging phenotype using F-fluorodeoxyglucose positron emission tomography-based radiomics and genetic alterations of pancreatic ductal adenocarcinoma. European journal of nuclear medicine and molecular imaging 2020 Jan . Lim Chae Hong, Cho Young Seok, Choi Joon Young, Lee Kyung-Han, Lee Jong Kyun, Min Ji Hye, Hyun Seung Hy |
| SMAD4 Y353C promotes the progression of PDAC. BMC cancer 2019 Nov 19 (1): 1037. Wang Zusen, Li Yongxing, Zhan Shixiong, Zhang Lu, Zhang Shun, Tang Qian, Li Miaomiao, Tan Zhen, Liu Shiguo, Xing Xiaomi |
| Immunohistochemical profiling of liver metastases and matched-pair analysis in patients with metastatic pancreatic ductal adenocarcinoma. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2019 Sep . Held Thomas, Verbeke Caroline S, Strobel Oliver, Rutkowski Wiktor, Villard Christina, Moro Carlos Fernández, Del Chiaro Marco, Büchler Markus, Heuchel Rainer, Löhr Matthi |
| CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Abdominal radiology (New York) 2019 Jun . Attiyeh Marc A, Chakraborty Jayasree, McIntyre Caitlin A, Kappagantula Rajya, Chou Yuting, Askan Gokce, Seier Kenneth, Gonen Mithat, Basturk Olca, Balachandran Vinod P, Kingham T Peter, D'Angelica Michael I, Drebin Jeffrey A, Jarnagin William R, Allen Peter J, Iacobuzio-Donahue Christine A, Simpson Amber L, Do Richard |
| Immune-related somatic mutation genes are enriched in PDACs with diabetes. Translational oncology 2019 Jun 12 (9): 1147-1154. Wang Kaixuan, Zhou Wei, Meng Peng, Wang Peng, Zhou Chunhua, Yao Yao, Wu Shouxin, Wang Yu, Zhao Jiangman, Zou Duowu, Jin Ga |
| Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation. Human pathology 2019 Apr . Yatagai Noboru, Saito Tsuyoshi, Akazawa Yoichi, Hayashi Takuo, Yanai Yuka, Tsuyama Sho, Murakami Takashi, Ueyama Hiroya, Watanabe Sumio, Nagahara Akihito, Yao Takas |
| Genetic assessment of recurrent pancreatic high-risk lesions in the remnant pancreas: Metachronous multifocal lesion or local recurrence? Surgery 2019 Apr 165 (4): 767-774. Gotoh Yoshitaka, Ohtsuka Takao, Nakamura So, Shindo Koji, Ohuchida Kenoki, Miyasaka Yoshihiro, Mori Yasuhisa, Mochidome Naoki, Oda Yoshinao, Nakamura Masafu |
| The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic. Nature genetics 2019 Feb . Frankell Alexander M, Jammula SriGanesh, Li Xiaodun, Contino Gianmarco, Killcoyne Sarah, Abbas Sujath, Perner Juliane, Bower Lawrence, Devonshire Ginny, Ococks Emma, Grehan Nicola, Mok James, O'Donovan Maria, MacRae Shona, Eldridge Matthew D, Tavaré Simon, , Fitzgerald Rebecca |
| Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma? Oncotarget 2019 Jan 10 (7): 696-706. Gall Tamara M H, Gerrard Gareth, Frampton Adam E, Castellano Leandro, Ahmad Raida, Habib Nagy, Spalding Duncan, Pai Madhava, Foroni Letizia, Jiao Long |
| Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study. PloS one 2019 14 (2): e0212142. Liao Xiaoyan, Hao Yansheng, Zhang Xiaofei, Ward Stephen, Houldsworth Jane, Polydorides Alexandros D, Harpaz No |
| Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer. Molecular cancer therapeutics 2018 Oct . Wei Tao, Zhang Qi, Li Xiang, Su Wei, Li Guogang, Ma Tao, Gao Shunliang, Lou Jianying, Que Risheng, Zheng Lei, Bai Xueli, Liang Ting |
| Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics. Clinical colorectal cancer 2018 Jul . Khan Maliha, Loree Jonathan M, Advani Shailesh M, Ning Jing, Li Wen, Pereira Allan A L, Lam Michael, Raghav Kanwal, Morris Van K, Broaddus Russell, Maru Dipen, Overman Michael J, Kopetz Sco |
| Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma. Scientific reports 2018 May 8 (1): 8105. Takeuchi Shoko, Doi Manami, Ikari Naoki, Yamamoto Masakazu, Furukawa To |
| Lung cancer in never smokers from the Princess Margaret Cancer Centre. Oncotarget 2018 Apr 9 (32): 22559-22570. Korpanty Grzegorz J, Kamel-Reid Suzanne, Pintilie Melania, Hwang David M, Zer Alona, Liu Geoffrey, Leighl Natasha B, Feld Ronald, Siu Lillian L, Bedard Philippe L, Tsao Ming-Sound, Shepherd Frances |
| Exome-wide somatic mutation characterization of small bowel adenocarcinoma. PLoS genetics 2018 Mar 14 (3): e1007200. Hänninen Ulrika A, Katainen Riku, Tanskanen Tomas, Plaketti Roosa-Maria, Laine Riku, Hamberg Jiri, Ristimäki Ari, Pukkala Eero, Taipale Minna, Mecklin Jukka-Pekka, Forsström Linda M, Pitkänen Esa, Palin Kimmo, Välimäki Niko, Mäkinen Netta, Aaltonen Lauri |
| KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma. Histopathology 2018 Feb . Mehrad Mitra, Roy Somak, LaFramboise William A, Petrosko Patti, Miller Caitlyn, Incharoen Pimpin, Dacic San |
| HPV Status and Mutation Analysis Using Multiparallel Sequencing in Distal Oesophageal and Gastro-oesophageal Junction Adenocarcinomas. Folia biologica 2018 64 (2): 41-45. Vošmik M, Vošmiková H, Sieglová K, Sirák I, Laco J, Ryška A, Petera J, Melichar B, Soumarová |
| Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas. Lung cancer (Amsterdam, Netherlands) 2018 10 124 110-116. Jin Ying, Shi Xun, Zhao Jun, He Qiong, Chen Ming, Yan Junrong, Ou Qiuxiang, Wu Xue, Shao Yang W, Yu Xinm |
| Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. Cancer biomarkers : section A of Disease markers 2017 Oct . Masetti Michele, Acquaviva Giorgia, Visani Michela, Tallini Giovanni, Fornelli Adele, Ragazzi Moira, Vasuri Francesco, Grifoni Daniela, Giacomo Simone Di, Fiorino Sirio, Lombardi Raffaele, Tuminati David, Ravaioli Matteo, Fabbri Carlo, Bacchi-Reggiani Maria Letizia, Pession Annalisa, Jovine Elio, de Biase Dar |
| Genomic Profiling of Small-Bowel Adenocarcinoma. JAMA oncology 2017 Jun . Schrock Alexa B, Devoe Craig E, McWilliams Robert, Sun James, Aparicio Thomas, Stephens Philip J, Ross Jeffrey S, Wilson Richard, Miller Vincent A, Ali Siraj M, Overman Michael |
| Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes. Scientific reports 2017 Feb 7 41064. Schlitter Anna Melissa, Segler Angela, Steiger Katja, Michalski Christoph W, Jäger Carsten, Konukiewitz Björn, Pfarr Nicole, Endris Volker, Bettstetter Markus, Kong Bo, Regel Ivonne, Kleeff Jörg, Klöppel Günter, Esposito Ire |
| Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern. Journal of gastrointestinal oncology 2016 Dec 7 (6): 882-902. Al-Shamsi Humaid O, Jones Jeremy, Fahmawi Yazan, Dahbour Ibrahim, Tabash Aziz, Abdel-Wahab Reham, Abousamra Ahmed O S, Shaw Kenna R, Xiao Lianchun, Hassan Manal M, Kipp Benjamin R, Kopetz Scott, Soliman Amr S, McWilliams Robert R, Wolff Robert |
| Diagnosis of pancreatic lesions collected by endoscopic ultrasound-guided fine-needle aspiration using next-generation sequencing. Oncology letters 2016 Nov 12 (5): 3875-3881. Kameta Eri, Sugimori Kazuya, Kaneko Takashi, Ishii Tomohiro, Miwa Haruo, Sato Takeshi, Ishii Yasuaki, Sue Soichiro, Sasaki Tomohiko, Yamashita Yuki, Shibata Wataru, Matsumoto Naomichi, Maeda Sh |
| Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium). Oncotarget 2016 Apr . Lim Sun Min, Kim Hye Ryun, Cho Eun Kyung, Min Young Joo, Ahn Jin Seok, Ahn Myung-Ju, Park Keunchil, Cho Byoung Chul, Lee Ji-Hyun, Jeong Hye Cheol, Kim Eun Kyung, Kim Joo-Ha |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 20, 2022
- Content source: